<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:g-core="http://base.google.com/ns/1.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel rdf:about="http://www.progressnp.com">
    <title>Progress in Neurology and Psychiatry EarlyView RSS Feed</title>
    <link>http://www.progressnp.com</link>
    <description>Progress in Neurology and Psychiatry EarlyView RSS Feed</description>
    <items>
      <rdf:Seq>
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/738021/Digest.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/738029/Digest.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/738019/Computerised_cognitive_behavioural_therapy_and_its_uses.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/738027/Computerised_cognitive_behavioural_therapy_and_its_uses.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/738017/An_update_on_sleep_disorders_and_their_treatment.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/738025/An_update_on_sleep_disorders_and_their_treatment.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/738015/Compliance_and_how_to_achieve_it_the_commercial_approach.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/738023/Compliance_and_how_to_achieve_it_the_commercial_approach.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/685999/Digest.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/685997/Can_a_patientcentred_approach_to_epilepsy_improve_outcomes.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/685993/Management_of_eating_disorders_during_pregnancy.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/685991/Importance_of_diagnosing_sleep_disorders.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/685987/Audit_of_GP_practice_records_of_patients_prescribed_clozapine.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/685985/Crisis_resolution_in_older_peoples_mental_healthcare.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/571293/Digest.html" />
      </rdf:Seq>
    </items>
  </channel>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/738021/Digest.html">
    <title>Digest</title>
    <link>http://www.progressnp.com/details/journalArticle/738021/Digest.html</link>
    <description>Antidepressant use and learning disabilityAnalysis of the records of 221 adults attending the Welsh Centre for Learning Disability in Cardiff identified 241 episodes of treatment with an antidepressant within the past five years (The Psychiatrist 2010;34:123-6).Antidepressants were prescribed for depression in 61 per cent of cases, for generalised anxiety disorder in 10 per cent and obsessive-compulsive disorder in 10 per cent. SSRIs accounted for over three-quarters of agents prescribed, with...</description>
    <dc:date>2010-06-09T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/738029/Digest.html">
    <title>Digest</title>
    <link>http://www.progressnp.com/details/journalArticle/738029/Digest.html</link>
    <description>Antidepressant use and learning disabilityAnalysis of the records of 221 adults attending the Welsh Centre for Learning Disability in Cardiff identified 241 episodes of treatment with an antidepressant within the past five years (The Psychiatrist 2010;34:123-6).Antidepressants were prescribed for depression in 61 per cent of cases, for generalised anxiety disorder in 10 per cent and obsessive-compulsive disorder in 10 per cent. SSRIs accounted for over three-quarters of agents prescribed, with...</description>
    <dc:date>2010-06-09T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/738019/Computerised_cognitive_behavioural_therapy_and_its_uses.html">
    <title>Computerised cognitive behavioural therapy and its uses</title>
    <link>http://www.progressnp.com/details/journalArticle/738019/Computerised_cognitive_behavioural_therapy_and_its_uses.html</link>
    <description>The use of computer software programmes to deliver cognitive behavioural therapy to people with mental health disorders is becoming increasingly popular. Here the authors describe what conditions computerised cognitive behavioural therapy may be useful for, discuss its advantages and disadvantages and outline the current NICE guidance on its use. Copyright © 2010 Wiley Interface Ltd</description>
    <dc:date>2010-06-09T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/738027/Computerised_cognitive_behavioural_therapy_and_its_uses.html">
    <title>Computerised cognitive behavioural therapy and its uses</title>
    <link>http://www.progressnp.com/details/journalArticle/738027/Computerised_cognitive_behavioural_therapy_and_its_uses.html</link>
    <description>The use of computer software programmes to deliver cognitive behavioural therapy to people with mental health disorders is becoming increasingly popular. Here the authors describe what conditions computerised cognitive behavioural therapy may be useful for, discuss its advantages and disadvantages and outline the current NICE guidance on its use. Copyright © 2010 Wiley Interface Ltd</description>
    <dc:date>2010-06-09T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/738017/An_update_on_sleep_disorders_and_their_treatment.html">
    <title>An update on sleep disorders and their treatment</title>
    <link>http://www.progressnp.com/details/journalArticle/738017/An_update_on_sleep_disorders_and_their_treatment.html</link>
    <description>Over the past year, Progress in Neurology and Psychiatry has been running a series of articles on the major psychiatric drug groups, produced in association with the College of Mental Health Pharmacy. In the final article in the series, Michele Sie describes the main types of sleep disorder and their features, and provides an overview of their treatment. Copyright © 2010 Wiley Interface Ltd</description>
    <dc:date>2010-06-09T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/738025/An_update_on_sleep_disorders_and_their_treatment.html">
    <title>An update on sleep disorders and their treatment</title>
    <link>http://www.progressnp.com/details/journalArticle/738025/An_update_on_sleep_disorders_and_their_treatment.html</link>
    <description>Over the past year, Progress in Neurology and Psychiatry has been running a series of articles on the major psychiatric drug groups, produced in association with the College of Mental Health Pharmacy. In the final article in the series, Michele Sie describes the main types of sleep disorder and their features, and provides an overview of their treatment. Copyright © 2010 Wiley Interface Ltd</description>
    <dc:date>2010-06-09T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/738015/Compliance_and_how_to_achieve_it_the_commercial_approach.html">
    <title>Compliance and how to achieve it: the commercial approach</title>
    <link>http://www.progressnp.com/details/journalArticle/738015/Compliance_and_how_to_achieve_it_the_commercial_approach.html</link>
    <description>No Abstract.</description>
    <dc:date>2010-06-09T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/738023/Compliance_and_how_to_achieve_it_the_commercial_approach.html">
    <title>Compliance and how to achieve it: the commercial approach</title>
    <link>http://www.progressnp.com/details/journalArticle/738023/Compliance_and_how_to_achieve_it_the_commercial_approach.html</link>
    <description>No Abstract.</description>
    <dc:date>2010-06-09T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/685999/Digest.html">
    <title>Digest</title>
    <link>http://www.progressnp.com/details/journalArticle/685999/Digest.html</link>
    <description>Phase III trials demonstrate promise for new oral treatmentsNovartis's fingolimod, a sphingosine-1-phosphate receptor modulator that reduces lymphocyte infiltration into the CNS and may also have neuroprotective activity, has been compared with placebo (New Engl J Med 2010;362:387-401) and interferon beta-1a (New Engl J Med 2010;362:402-15) in patients with relapsing-remitting MS and milder disability (Expanded Disability Status Scale (EDSS) score 0-5.5) an average of seven to eight years...</description>
    <dc:date>2010-04-16T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/685997/Can_a_patientcentred_approach_to_epilepsy_improve_outcomes.html">
    <title>Can a patient-centred approach to epilepsy improve outcomes?</title>
    <link>http://www.progressnp.com/details/journalArticle/685997/Can_a_patientcentred_approach_to_epilepsy_improve_outcomes.html</link>
    <description>It is recognised that antiepileptic drug choice is driven by the desire for seizure control, but patient quality of life and consideration of other factors are also important for the treatment of the individual as a whole. In this expert panel discussion, three specialists discuss the benefits and potential for improved outcomes of a patient-centred approach to epilepsy management. Copyright © 2010 Wiley Interface Ltd</description>
    <dc:date>2010-04-16T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/685993/Management_of_eating_disorders_during_pregnancy.html">
    <title>Management of eating disorders during pregnancy</title>
    <link>http://www.progressnp.com/details/journalArticle/685993/Management_of_eating_disorders_during_pregnancy.html</link>
    <description>In Pregnancy is a series of reviews focusing on the management of women with psychiatric and neurological conditions during pregnancy. In this article, Dr Micali discusses how pregnancy may affect women with eating disorders, as well as the effect of eating disorders on pregnancy outcomes. Copyright © 2010 Wiley Interface Ltd</description>
    <dc:date>2010-04-16T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/685991/Importance_of_diagnosing_sleep_disorders.html">
    <title>Importance of diagnosing sleep disorders</title>
    <link>http://www.progressnp.com/details/journalArticle/685991/Importance_of_diagnosing_sleep_disorders.html</link>
    <description>No Abstract.</description>
    <dc:date>2010-04-16T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/685987/Audit_of_GP_practice_records_of_patients_prescribed_clozapine.html">
    <title>Audit of GP practice records of patients prescribed clozapine</title>
    <link>http://www.progressnp.com/details/journalArticle/685987/Audit_of_GP_practice_records_of_patients_prescribed_clozapine.html</link>
    <description>Patients prescribed clozapine have associated physical health risks because of both use of the drug itself and their underlying mental illness. It is therefore important that primary and secondary care work closely together to optimise patient care. Here, the authors describe their audit of patients prescribed clozapine in secondary care to identify whether they were registered on their GP practice's severe mental illness register and whether the practice had a record that they were taking...</description>
    <dc:date>2010-04-16T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/685985/Crisis_resolution_in_older_peoples_mental_healthcare.html">
    <title>Crisis resolution in older people's mental healthcare</title>
    <link>http://www.progressnp.com/details/journalArticle/685985/Crisis_resolution_in_older_peoples_mental_healthcare.html</link>
    <description>The Crisis Resolution and Home Treatment (CRHT) team's role in acute mental healthcare services for working age adults is well established throughout England, but this is less so for older adults despite government policy and initiatives promoting equality of care. The authors highlight the need to extend this care model to older people's mental healthcare and suggest some possible ways of achieving this. Copyright © 2010 Wiley Interface Ltd</description>
    <dc:date>2010-04-16T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/571293/Digest.html">
    <title>Digest</title>
    <link>http://www.progressnp.com/details/journalArticle/571293/Digest.html</link>
    <description>Migrainous vertigoMigraine and vertigo may occur together but there is little evidence to show whether drug treatment is effective. Investigators from Turkey have now evaluated prophylaxis with topiramate 50 or 100mg daily in 30 women meeting published criteria for ‘migrainous vertigo’ in whom Meniere's disease had been excluded (Headache 2010;50:77-84).Over 24 weeks, topiramate reduced the mean frequency of vertigo attacks compared with pretreatment levels from 8.1 to 2.3 per month and...</description>
    <dc:date>2010-02-16T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

